Skip to content
Wednesday, August 26, 2026
1 WOMEN'S HEALTHWOMEN'S & REPRODUCTIVE HEALTH

Women's Health Trial Tracker — 2015

RecordRecord DateVuga GroupChange StatusRecency DaysPublic Significance Score
Trial of Perioperative Endocrine Therapy - Individualising Care01/14/2015INTERVENTIONALunchanged4,242.850
Breast Reconstruction With External Pre-expansion and Autologous Fat Transfer Versus Standard Therapy01/15/2015INTERVENTIONALunchanged4,241.850
Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer01/26/2015INTERVENTIONALunchanged4,230.850
A Trial of Vigil for Participants With Ovarian Cancer01/27/2015INTERVENTIONALunchanged4,229.850
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ02/02/2015INTERVENTIONALunchanged4,223.850
GnRH for Luteal Support in IVF/ICSI/FET Cycles02/06/2015INTERVENTIONALunchanged4,219.850
Assessing the Impact of Contraceptives on Bone Health Using 41Ca02/20/2015INTERVENTIONALunchanged4,205.850
Node Negative, Invasive Breast Cancer Single Fraction IOERT02/25/2015INTERVENTIONALunchanged4,200.850
Sequence Variations of Genes in the Estrogen Pathway and Perinatal Depression02/27/2015OBSERVATIONALunchanged4,198.850
Swedish Iodine in Pregnancy and Development in Children (SWIDDICH) Study03/04/2015INTERVENTIONALunchanged4,193.850
Longitudinal Study of Intra-Uterine Growth Restriction03/09/2015OBSERVATIONALunchanged4,188.850
Hypofractionated Loco-regional Adjuvant Radiation Therapy of Breast Cancer Combined With a Simultaneous Integrated Boost03/10/2015INTERVENTIONALunchanged4,187.850
Effects of High Altitude on AMPK Activation03/18/2015OBSERVATIONALunchanged4,179.850
Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)03/19/2015INTERVENTIONALunchanged4,178.850
Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer03/24/2015INTERVENTIONALunchanged4,173.850
The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)03/26/2015INTERVENTIONALunchanged4,171.850
Efficacy of IORT With CT-Guided HDR Brachytherapy for Treatment of Breast Cancer03/27/2015INTERVENTIONALunchanged4,170.850
POSNOC - A Trial Looking at Axillary Treatment in Early Breast Cancer03/30/2015INTERVENTIONALunchanged4,167.850
Positive Airway Pressure, Sleep Apnea, and the Placenta (PAP-SAP)04/09/2015INTERVENTIONALunchanged4,157.850
Homologous Recombination Repair Status as a Biomarker of Response in Locally Recurrent/Metastatic Triple Negative Breast Cancer Patients Treated With Concurrent Cisplatin and Radiation Therapy04/21/2015INTERVENTIONALunchanged4,145.850
Cyrolipolysis vs Cyrolipolysis and Subcision for Cellulite04/28/2015INTERVENTIONALunchanged4,138.850
TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors04/29/2015INTERVENTIONALunchanged4,137.850
TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors04/29/2015INTERVENTIONALunchanged4,137.850
Study of Preservation of Ovarian Reserve During Chemotherapy for Young Breast Cancer Patients04/30/2015OBSERVATIONALunchanged4,136.850
Safety and Durability of Sirolimus for Treatment of LAM05/04/2015OBSERVATIONALunchanged4,132.850
Vitamin D and Angiogenic Markers in Odense Child Cohort 105/06/2015OBSERVATIONALunchanged4,130.850
Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab05/07/2015INTERVENTIONALunchanged4,129.850
Placental Passage and Disposition of Drugs: A Physiology-based Approach05/08/2015OBSERVATIONALunchanged4,128.850
The Vitamin D and Fetal Bone Length Study (VITFBL)05/08/2015OBSERVATIONALunchanged4,128.850
Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer05/18/2015INTERVENTIONALunchanged4,118.850
Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer05/27/2015INTERVENTIONALunchanged4,109.850
Feasibility and Identification of Breast Cancer Patients for Potential Avoidance of Surgery05/28/2015INTERVENTIONALunchanged4,108.850
Infant Microbiota and Probiotic Intake Study05/29/2015INTERVENTIONALunchanged4,107.850
Rapid Pancreatic and Ovarian Screening MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion Weighted Imaging for Patients With BRCA Mutation Who Undergo Screening Breast MRI06/04/2015OBSERVATIONALunchanged4,101.850
Comparison of Axillary Sentinel Lymph Node Biopsy Versus no Axillary Surgery06/09/2015INTERVENTIONALunchanged4,096.850
Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers06/09/2015INTERVENTIONALunchanged4,096.850
Ovarian Reserve After Cancer: Longitudinal Effects06/09/2015OBSERVATIONALunchanged4,096.850
Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine Candidates06/15/2015OBSERVATIONALunchanged4,090.850
Laparoscopic Surgery for Severe Recto-vaginal Endometriosis06/15/2015OBSERVATIONALunchanged4,090.850
Hypofractionation With Simultaneous Integrated Boost vs. Standard Fractionation in Early Breast Cancer06/18/2015INTERVENTIONALunchanged4,087.850
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score06/19/2015INTERVENTIONALunchanged4,086.850
Preoperative Single-Fraction Radiotherapy in Early Stage Breast Cancer06/26/2015INTERVENTIONALunchanged4,079.850
The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer06/30/2015INTERVENTIONALunchanged4,075.850
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma07/01/2015INTERVENTIONALunchanged4,074.850
A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer07/02/2015INTERVENTIONALunchanged4,073.850
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical Cancer07/07/2015INTERVENTIONALunchanged4,068.850
A Phase II Evaluation of Afatinib in Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma07/07/2015INTERVENTIONALunchanged4,068.850
Management of Low-risk (Grade I and II) DCIS07/08/2015INTERVENTIONALunchanged4,067.850
Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer07/10/2015INTERVENTIONALunchanged4,065.850
White Adipose Tissue in Pregnancy Study07/14/2015OBSERVATIONALunchanged4,061.850
Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors07/15/2015INTERVENTIONALunchanged4,060.850
Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer07/20/2015INTERVENTIONALunchanged4,055.850
Eat, Move, Live Intervention in Reducing Chronic Disease Risk in Medically Vulnerable Communities07/31/2015INTERVENTIONALunchanged4,044.850
Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer08/04/2015INTERVENTIONALunchanged4,040.850
Breast Cancer 2-PREVENT Translational Center of Excellence (TCE) - Metastatic Markers of Recurrent Tumor Phenotype for Breast Cancer08/20/2015OBSERVATIONALunchanged4,024.850
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH08/20/2015INTERVENTIONALunchanged4,024.850
Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women With Non-Metastatic Breast Cancer08/20/2015OBSERVATIONALunchanged4,024.850
Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer08/28/2015INTERVENTIONALunchanged4,016.850
Preovulatory Uterine Flushing With Saline as a Treatment for Unexplained Infertility09/03/2015INTERVENTIONALunchanged4,010.850
Acute and Long-term Cardiovascular Toxicity After Modern Radiotherapy for Breast Cancer09/04/2015OBSERVATIONALunchanged4,009.850
Biomarker Guided Treatment in Gynaecological Cancer09/07/2015INTERVENTIONALunchanged4,006.850
Treatments for Urogynaecological Problems and Patient Selfreports09/15/2015OBSERVATIONALunchanged3,998.850
Fetoscopic Endoluminal Tracheal Occlusion in Severe Left Congenital Diaphragmatic Hernia09/15/2015INTERVENTIONALunchanged3,998.850
Neoadjuvant Lenvatinib Combined With Letrozole in Hormone Receptor Positive Breast Cancer09/29/2015INTERVENTIONALunchanged3,984.850
Effect of Brief-tele Support on Attendance at Physiotherapy Sessions09/30/2015INTERVENTIONALunchanged3,983.850
Safety and Efficacy of Omission of Sentinel Node Biopsy in Patients With Estrogen-Positive Breast Cancer Over Age 6510/01/2015INTERVENTIONALunchanged3,982.850
Muscle Loss and Fatigue as a Consequence of Radiotherapy10/05/2015OBSERVATIONALunchanged3,978.850
PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer10/08/2015INTERVENTIONALunchanged3,975.850
Uterine Transplantation for the Treatment of Uterine Factor Infertility10/09/2015INTERVENTIONALunchanged3,974.850
Neuromodulation as a Treatment for Chemotherapy-Induced Peripheral Neuropathy10/12/2015INTERVENTIONALunchanged3,971.850
PIERS and BIS, sFIT:PIGF, Adrenomedullin10/19/2015OBSERVATIONALunchanged3,964.850
Toronto Gestational Glucose Tolerance Cohort10/21/2015OBSERVATIONALunchanged3,962.850
Investigating the Impact of Obesity on Pubertal Development in Girls10/22/2015OBSERVATIONALunchanged3,961.850
Beauty from Within Community Screening Project10/28/2015OBSERVATIONALunchanged3,955.850
Anisotropic Textile Braces for Adolescent Idiopathic Scoliosis10/28/2015INTERVENTIONALunchanged3,955.850
Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors10/30/2015INTERVENTIONALunchanged3,953.850
Vasculitis Pregnancy Registry11/02/2015OBSERVATIONALunchanged3,950.850
AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE)11/03/2015OBSERVATIONALunchanged3,949.850
Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer11/04/2015INTERVENTIONALunchanged3,948.850
Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer11/04/2015INTERVENTIONALunchanged3,948.850
Fetoscopic Endoluminal Tracheal Occlusion (FETO) for Congenital Diaphragm Hernia11/04/2015INTERVENTIONALunchanged3,948.850
Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.11/05/2015INTERVENTIONALunchanged3,947.850
Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies With Alpha Beta TCell and B Cell Depletion Using the CliniMACS Device11/09/2015INTERVENTIONALunchanged3,943.850
Latent Structure of Multi-level Assessments and Predictors of Outcomes for Women in Recovery11/10/2015OBSERVATIONALunchanged3,942.850
Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)11/16/2015INTERVENTIONALunchanged3,936.850
[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer11/18/2015INTERVENTIONALunchanged3,934.850
Strawberry Candy Twists as an Alternative Screen for Gestational Diabetes: A Prospective Trial11/20/2015INTERVENTIONALunchanged3,932.850
THE INFLUENCE OF COGNITIVE BEHAVIORAL THERAPY IN SEXUAL DYSFUNCTION FEMALE: Randomized Clinical Trial11/24/2015INTERVENTIONALunchanged3,928.850
Tomosynthesis Mammographic Imaging Screening Trial11/27/2015INTERVENTIONALunchanged3,925.850
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)12/03/2015INTERVENTIONALunchanged3,919.850
Adjuvant Trastuzumab, Pertuzumab Plus Docetaxel in the Treatment of Early HER2-positive Breast Cancer12/09/2015INTERVENTIONALunchanged3,913.850
Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer12/11/2015INTERVENTIONALunchanged3,911.850
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT12/22/2015INTERVENTIONALunchanged3,900.850
TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA Signature12/30/2015INTERVENTIONALunchanged3,892.850
Sentinel Lymph Node Biopsy Versus Pelvic Lymphadenectomy in Early-stage Cervical Cancer (PHENIX/CSEM 010)12/30/2015INTERVENTIONALunchanged3,892.850
Lateral Episiotomy or Not in Vacuum Assisted Delivery in Non-parous Women12/30/2015INTERVENTIONALunchanged3,892.850